Home Applications 210453 Application 210453
Type ANDA
Sponsor AUROBINDO PHARMA LTD Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 GUAIFENESIN GUAIFENESIN TABLET, EXTENDED RELEASE;ORAL 600MG No No 002 GUAIFENESIN GUAIFENESIN TABLET, EXTENDED RELEASE;ORAL 1.2GM No No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A210453-001 GUAIFENESIN GUAIFENESIN 600MG TABLET, EXTENDED RELEASE / ORAL 2019-10-21 A210453-002 GUAIFENESIN GUAIFENESIN 1.2GM TABLET, EXTENDED RELEASE / ORAL 2019-10-21
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 3 of 3 · 86 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2022-09-29 23:25 UTC 2022-09 A210453-001 GUAIFENESIN 600MG TABLET, EXTENDED RELEASE / ORAL 2019-10-21 e64feba35796…2022-09-29 23:25 UTC 2022-09 A210453-002 GUAIFENESIN 1.2GM TABLET, EXTENDED RELEASE / ORAL 2019-10-21 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 A210453-001 GUAIFENESIN 600MG TABLET, EXTENDED RELEASE / ORAL 2019-10-21 cb3db0bc1861…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 A210453-002 GUAIFENESIN 1.2GM TABLET, EXTENDED RELEASE / ORAL 2019-10-21 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A210453-001 GUAIFENESIN 600MG TABLET, EXTENDED RELEASE / ORAL 2019-10-21 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A210453-002 GUAIFENESIN 1.2GM TABLET, EXTENDED RELEASE / ORAL 2019-10-21 a50c72e98297…
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 17 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 41 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 0363-0028 Guaifenesin Guaifenesin WALGREEN CO. ANDA Current 0363-0028 Guaifenesin Guaifenesin WALGREEN CO. ANDA Current 0363-0028 Guaifenesin Guaifenesin WALGREEN CO. ANDA Current 0363-0028 Guaifenesin Guaifenesin WALGREEN CO. ANDA Current 0363-0033 Guaifenesin Guaifenesin WALGREEN CO. ANDA Current 0363-0033 Guaifenesin Guaifenesin WALGREEN CO. ANDA Current 0363-0033 Guaifenesin Guaifenesin WALGREEN CO. ANDA Current 0363-0033 Guaifenesin Guaifenesin WALGREEN CO. ANDA Current 0363-0033 Guaifenesin Guaifenesin WALGREEN CO. ANDA Current 11822-4260 Guaifenesin Guaifenesin RITE AID CORPORATION ANDA Current 21130-179 Guaifenesin Guaifenesin Better Living Brands LLC ANDA Current 21130-399 MUCUS RELIEF MAX Guaifenesin Better Living Brands, LLC ANDA Current 21130-399 MUCUS RELIEF MAX Guaifenesin Better Living Brands, LLC ANDA Current 21130-399 MUCUS RELIEF MAX Guaifenesin Better Living Brands, LLC ANDA Current 21130-399 MUCUS RELIEF MAX Guaifenesin Better Living Brands, LLC ANDA Current 55319-902 Guaifenesin Guaifenesin Family Dollar, Inc. ANDA Current 55319-902 Guaifenesin Guaifenesin Family Dollar, Inc. ANDA Current 58602-810 Guaifenesin Guaifenesin Aurohealth LLC ANDA Current 58602-810 Guaifenesin Guaifenesin Aurohealth LLC ANDA Current 58602-810 Guaifenesin Guaifenesin Aurohealth LLC ANDA Current 58602-810 Guaifenesin Guaifenesin Aurohealth LLC ANDA Current 58602-810 Guaifenesin Guaifenesin Aurohealth LLC ANDA Current 58602-811 Guaifenesin Guaifenesin Aurohealth LLC ANDA Current 58602-811 Guaifenesin Guaifenesin Aurohealth LLC ANDA Current 58602-811 Guaifenesin Guaifenesin Aurohealth LLC ANDA Current 58602-811 Guaifenesin Guaifenesin Aurohealth LLC ANDA Current 58602-811 Guaifenesin Guaifenesin Aurohealth LLC ANDA Current 58602-811 Guaifenesin Guaifenesin Aurohealth LLC ANDA Current 58602-853 Guaifenesin Guaifenesin Aurohealth LLC ANDA Current 58602-853 Guaifenesin Guaifenesin Aurohealth LLC ANDA Current 58602-853 Guaifenesin Guaifenesin Aurohealth LLC ANDA Current 58602-853 Guaifenesin Guaifenesin Aurohealth LLC ANDA Current 58602-864 Guaifenesin Guaifenesin Aurohealth LLC ANDA Current 58602-864 Guaifenesin Guaifenesin Aurohealth LLC ANDA Current 58602-865 Guaifenesin Guaifenesin Aurohealth LLC ANDA Current 58602-865 Guaifenesin Guaifenesin Aurohealth LLC ANDA Current 68001-561 Guaifenesin Guaifenesin BluePoint Laboratories ANDA Current 71179-002 Guaifenesin Guaifenesin VESPYR BRANDS, INC. ANDA Current 79395-001 Guaifenesin Guaifenesin Chalkboard Health ANDA Current 79395-001 Guaifenesin Guaifenesin Chalkboard Health ANDA Current 79395-001 Guaifenesin Guaifenesin Chalkboard Health ANDA Current